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Infertility is a condition in women’s life which 
indicates inability to procreate. Conception depends 
on multiple factors, ovulation being one among them. 
A remarkable decline in human fertility is observed 
beyond the age of 30 years due to reduction in quality 
and number of healthy ovum. Anovulation is reported 
to be one of the major cause for female infertility 
ranging up to 25 - 40% of infertile women.
[1] 
If the 
menstrual cycles followed by ovulation are related to 
an   outside    influence    like   nutrition    or   lifestyle, 
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effective treatments will include regulating eating 
habits and moderating physical activities. Making 
changes to one’s weight (gaining or losing weight) 
may also be enough to jump-start stalled ovulation. 
Sometimes internal imbalances are the reason and in 
such cases, medications are to be prescribed for 
fertility. These medications are designed to combat 
the cause of a woman’s infertility. There are drugs 
designed to ripen the follicles, increase estrogen and 
help the ovaries release an egg.
[2]
 
In Ayurveda, four Garbha Sambhava Samagri are 
enumerated as Ritu, Kshetra, Ambu and Beeja. Any 
abnormalities in any of these affect the formation and 
development of Garbha. 
According to Shabdakalpadhruma, a women who has 
hindrance of any kind, in the normal process of 
conception is termed as Vandhya. Infertility according 
to Ayurveda is not only limited to non-achievement of 
conception but also includes failure to continue it till 
viability and birth of a healthy live child. In this 
Pumbheeja (Shukra) and Streebheeja (Artava) are very 
much important.
[3] 
Artavanasha is due to Avarana in 
Artavavaha Srotas.
[4] 
Ashvagandha is mentioned in 
A B S T R A C T  
Fertility is an existential necessity and as such has assumed over whelming importance from time 
immemorial. However, not all couples who desire a pregnancy will achieve one spontaneously and a 
proportion of couples will need medical help to resolve underlying fertility problems. Infertility has 
been recognized as a public health issue world wide by the World Health Organization. Infertility 
severely affects the couples psychologically, sexually and socially. Anovulation accounts for 25 - 40% 
of the female infertility. Ayurveda offers several potent combinations in such a condition. The aim of 
the present paper is to address this problem by studying the efficacy of Ashvagandha Ksheerapaka in 
the induction of ovulation. 
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the treatment of Stree Vandhyatva.
[5]
 Studies on 
Ashvagandha shows significant increase in ovarian 
function and folliculogenesis.
[6] 
This paper intends to 
describe the efficacy of Ashvagandha Ksheerapaka in 
Stree Vandhyatva w.s.r. to anovulation. 
MATERIALS AND METHODS  
Total 30 women fulfilling the inclusion criteria were 
selected from outpatient and inpatient department of 
P.G. Studies in Prasuti Tantra and Stree Roga, S.D.M. 
College of Ayurveda and Hospital, Hassan in a single 
group and were studied. The drug Ashvagandha 
Choorna was obtained from the pharmacy of SDM 
Centre for Research in Ayurveda and Allied Sciences, 
Udupi for the present study. The Ethical Clearance for 
the study was obtained from Institutional ethical 
committee. The informed and written consent along 
with specially designed Case Proforma for the study 
was prepared.  
Inclusion Criteria 
1. Females of age group of 20 - 35 years.  
2. Females with normally developed secondary 
sexual characters, ovary and uterus.  
3. Women who are diagnosed with anovulatory 
cycles and single or multiple cyst in either of the 
ovaries.  
4. Patients who were ready to sign in the informed 
consent form.  
Exclusion Criteria 
1. Known case of genetic abnormalities.  
2. Known case of chronic systemic disorders 
(diabetes mellitus, hypertension, tuberculosis) 
and endocrinal disorders. (thyroid dysfunction). 
Criteria for diagnosis 
1. Female patients of primary and secondary 
infertility were assessed for Anovulation.  
2. Anovulation was confirmed by USG - Follicular 
study.  
Drug - Ashvagandha Ksheerapaka (Sharangadhara 
method 1:4:8 ratio) in a dose 100ml twice a day 
before food administered Orally. 
Duration - Consecutive 3 cycle (from 5th day after 
cessation of menses till the commencement of next 
menstrual cycle)  
Criteria for Assessment 
Sonological Parameters - Follicular study was 
repeated after completion of oral intake of 
Ashvagandha Ksheerapaka for three menstrual cycles. 
Efficacy of therapy was assessed on the basis of size of 
follicles, endometrial thickness and signs of ovulation.  
Patients were divided to following categories for 
assessment of follicle development and size.  
 Grade 0 = < 12mm follicle 
 Grade 1 = 12 - 19mm follicle  
 Grade 2 = 19 - 23mm follicle 
 Grade 3 = ovulation 
Overall effect of treatment 
1 Grade 3  Conceived  
The patient conceived 
after the treatment.  
2 Grade 2  Ovulated  Ovulation occurred  
3 Grade 1 Improved  
Ovulation not 
occurred but only 
improvement in the 
size of follicles i.e. 12-
19 mm.  
4 Grade 0  Unchanged  
No change in the 
growth of the follicle  
Follow up study was conducted every 15 days and 
also on 12
th
 day of menstrual cycle for follicular study 
after completion of the treatment. 
OBSERVATION 
Total 30 subjects registered and all 30 patients 
completed the study. The data collected from the 
proforma was subjected to statistical methods using 
SPSS (version 16) with Friedman’s test and Wilcoxon’s 
signed rank test which were filled on the starting of 
the first day of the treatment. All patients in the 
present study were having proper development and 
proper fat distribution on pubis and vulva. Average 
vaginal discharge was observed in 76.7% of patients, 
while cervical erosion was found in 13.3% of patients. 
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96.7% of patients were having nulliparous cervix. All 
of patients were having normal size uterus. 100% of 
patients had freely mobile uterus and fornices were 
clear. 
After the treatment among 30 patients, in maximum 
93.3% there was no change observed in the growth of 
the follicles, where as in 6.7%, there was slight 
improvement in follicular growth also the endometrial 
thickness, but it was not statistically significant. 
RESULTS 
Table 1: Showing USG - Follicular study reports of 30 
patients. 
Factors No of 
patients 
% 









Ovulated 00 00 









Ovulated 00 00 









Ovulated 00 00 









Ovulated 00 00 
Endometrial 
thickness 
BT <6mm 10 33.3 
6-8mm 19 63.3 
>8mm 01 3.3 
AT 6mm 08 26.7 
6-8mm 22 73.3 
>8mm 00 00 
Free fluid in 
POD 
BT Present 00 00 
AT Absent 30 100 
Among 30 patients before treatment 63.3% patients 
had <12mm follicular size, 33.3% patients had 
follicular size in between 12 - 19 and 3.3% had 19 - 
23mm follicle size in right ovary, in left ovary 80% had 
<12mm follicular size, 10% each had 12 - 19mm and 
19 - 23mm sized follicle with ET 6 - 8mm in 63.3%, 
<6mm in 33.3% and >8mm in 3.3% with no free fluid 
in POD. Whereas after treatment 63.3% patients had 
<12mm follicular size, 33.3% patients had follicular 
size in between 12 - 19mm and 3.3% had 19 - 23mm 
follicle size in right ovary, in left ovary 73.3% had 
<12mm follicular size, 16.7% had 12 - 19mm and 
10.0% had 19 - 23mm sized follicle with ET 6-8mm in 
73.3%, <6mm in 26.7% with no free fluid in POD. 
Table 2: Showing Friedman Test  




Right ovary 30 0.000 01 1.000 NS 
Left ovary 30 1.000 01 0.317 NS 
Endometrial 
thickness 
30 0.077 01 0.782 NS 
Free fluid in 
POD 
30 - 01 - NS 
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Friedman’s test shows that the trial drug is not giving 
statistically significant result in induction of ovulation. 
























































































































Bonferroni correction - 0.01, N - No., MR - Mean Rank, SR - Sum of 
Ranks 
Wilcoxon signed rank test shows that the trial drug is 
not giving statistically significant result in induction of 
ovulation. 
Among 30 patients maximum 93.3% there was no 
change observed in the growth of the follicles where 
as in 6.7% there is slight improvement in follicular 
growth also the endometrial thickness. But this is not 
statistically significant. 
CONCLUSION 
The present work was designed to study the efficacy 
of Ashvagandha Ksheerapaka in Stree Vandhyatva on 
anovulation. The effect of Ashvagandha Ksheerapaka 
is not clinically and statistically significant on 
ovulation. Better result may be achieved after 
Shodhana along with the administration of other 
Prajasthapanagana Dravya or Pumsavana Dravya or 
other compound medicine. Anyhow, no adverse drug 
reaction (ADR) and side effects were reported in the 
present study and the drug in the prescribed dose and 
the method used for the procedures proved safe.  
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